CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 143,200 Value ($000) $5,855 Avg Close — Range —
Q1 2024
Shares 143,200 Value ($000) $6,053 Avg Close — Range —
Q4 2023
Shares 139,700 Value ($000) $5,923 Avg Close — Range —
Q3 2023
Shares 137,900 Value ($000) $3,010 Avg Close — Range —
Q2 2023
Shares 136,400 Value ($000) $4,336 Avg Close — Range —
Q1 2023
Shares 135,000 Value ($000) $3,293 Avg Close — Range —
Q4 2022
Shares 150,500 Value ($000) $4,747 Avg Close — Range —
Q3 2022
Shares 140,700 Value ($000) $3,976 Avg Close — Range —
Q2 2022
Shares 138,800 Value ($000) $3,670 Avg Close — Range —
Q1 2022
Shares 104,400 Value ($000) $3,655 Avg Close — Range —
Q4 2021
Shares 95,600 Value ($000) $3,099 Avg Close — Range —
Q3 2021
Shares 93,400 Value ($000) $2,755 Avg Close — Range —
Q2 2021
Shares 70,100 Value ($000) $1,796 Avg Close — Range —